ellipticine has been researched along with mocetinostat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Eckschlager, T; Frei, E; Hrabeta, J; Hrebacková, J; Kizek, R; Martínek, V; Poljaková, J; Smutný, S; Stiborová, M | 1 |
| Frei, E; Rupertová, M; Stiborová, M | 1 |
| Li, X; Mulati, M; Qian, F; Sun, L; Ye, C | 1 |
1 review(s) available for ellipticine and mocetinostat
| Article | Year |
|---|---|
Cytochrome P450- and peroxidase-mediated oxidation of anticancer alkaloid ellipticine dictates its anti-tumor efficiency.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Cytochrome P-450 Enzyme System; Ellipticines; Humans; Molecular Structure; Oxidation-Reduction; Peroxidase | 2011 |
2 other study(ies) available for ellipticine and mocetinostat
| Article | Year |
|---|---|
The mechanism of cytotoxicity and DNA adduct formation by the anticancer drug ellipticine in human neuroblastoma cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Survival; Chromatography, High Pressure Liquid; Cyclooxygenase 1; Cyclooxygenase 2; Cytochrome P-450 Enzyme System; DNA Adducts; Dose-Response Relationship, Drug; Ellipticines; Humans; Peroxidase | 2009 |
Ellipticine blocks synergistic effects of IL-17A and TNF-α in epithelial cells and alleviates severe acute pancreatitis-associated acute lung injury.
Topics: Acute Lung Injury; Adaptor Proteins, Signal Transducing; Amylases; Animals; Anti-Inflammatory Agents; Cell Line, Transformed; Ceruletide; Disease Models, Animal; Ellipticines; Epithelial Cells; Gene Expression Regulation; HEK293 Cells; Humans; Interleukin-17; Lipase; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Pancreatitis; Peroxidase; Signal Transduction; TNF Receptor-Associated Factor 6; Tumor Necrosis Factor-alpha | 2020 |